NanoViricides Inc. (NNVC)

[arvitar]

It depends how fast they spend it, right?

Cash and cash equivalents at end of Sept was $6M, with liabilities in accounts payable over $1M, giving them $5M. Two months ago.

Diwan could have stopped all Theracour payements (doubtful), and fired everyone else, allowing him to go on for the next ten years paying himself $500K/year.

Or, NNVC could have paid him whatever was left in their bank account for rights to VZV, and NNVC will be insolvent tomorrow.

Neither you, nor anyone else, can say without knowing the details of their ongoing financial activity.